Patent · US Active

Nicotinamide riboside for use in treating or preventing liver damage

US12128060B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

ELYSIUM HEALTH, INC. · US

Inventors

Ryan Dellinger · Azusa, US
Santiago Roel Santos · New York, US
Eric Marcotulli · New York, US
Daniel A. Alminana · New York, US
Mark A. Morris · Somerville, US
Leonard Pershing Guarente · Newton, US

Key dates

Filing date	Jun 16, 2022
Grant date	Oct 29, 2024
Priority date	—
Expiry date	Jun 16, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.